key: cord-0864386-4mttr8a8 authors: Looi, Jeffrey CL; Allison, Stephen; Bastiampillai, Tarun; Maguire, Paul A title: What should psychiatrists advise their patients regarding COVID-19 protective measures and vaccination? date: 2022-02-08 journal: Australas Psychiatry DOI: 10.1177/10398562211060716 sha: 1f181f9deb50af99c3f4c6b3160438c1add300a1 doc_id: 864386 cord_uid: 4mttr8a8 nan What should psychiatrists advise their patients regarding COVID-19 protective measures and vaccination? Dear Sir, There is now widespread availability of COVID-19 vaccinations in Australia. However, our patients are exposed to media regarding vaccine hesitancy and misinformation 1 about COVID-19. 2 Therefore, practical medical advice regarding COVID-19 protective measures and vaccination is crucial. Psychiatrists can provide essential advice for people with serious mental illness, for whom, due to their increased risks of morbidity and mortality, vaccination is a priority. 3 Behavioural science research shows promoting cooperative behaviour to act for the common good is effective to increase uptake of protective measures. 4 Modelling of behaviour by trusted community members, especially doctors, is effective. 4 Recent research shows that people with serious mental illnesses, such as schizophrenia, and youth at highrisk for psychosis are willing to adhere to pandemic protective measures, such as physical distancing and handwashing, despite disability and social disadvantage. 5 Jeffrey CL Looi  https://orcid.org/0000-0003-3351-6911 Stephen Allison  https://orcid.org/0000-0002-9264-5310 Disinformation, misinformation and inequality-driven mistrust in the time of COVID-19: lessons unlearned from AIDS Denialism Confidence and receptivity for COVID-19 vaccines: a rapid systematic review. Basel: Vaccines Maximizing the Uptake of a COVID-19 Vaccine in people with severe mental illness: a public health priority Using social and behavioural science to support COVID-19 pandemic response Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis